CurrentAmbetter NevadaPolicy CP.MP.133

Posterior Tibial Nerve Stimulation for Voiding Dysfunction

Defines medical necessity criteria, coding guidance, and coverage stance for percutaneous posterior tibial nerve stimulation to treat overactive bladder (OAB) and related voiding dysfunction for Ambetter Nevada members.

Policy Summary

PayerAmbetter Nevada

PolicyPosterior Tibial Nerve Stimulation for Voiding Dysfunction

Policy CodePolicy CP.MP.133

Change TypeRevisions to conservative management examples and coding updates

Effective Date

Next Review Date

Key ActionObtain prior authorization for percutaneous PTNS (CPT 64566) and document diagnosis of OAB, prior failure of conservative management, and planned 12 weekly 30-minute sessions.

SourceLink

POLICY UPDATE CHANGES

Replaced 'investigational' language with 'insufficient evidence to support .'

Revised Criteria I.B. to include examples of behavioral therapies such as bladder training or pelvic floor muscle training and generalized 'medications used with the intent to treat OAB.'

Updated coding and descriptions; CPT coding implications reviewed and updated.

12initial weekly 30-minute sessions recommended

1monthly maintenance frequency (when responder)

64566CPT code that supports medical necessity

0587T-0590TCPT codes that do not support medical necessity (implantable systems / programming)

30 minusual stimulation duration per session

Coverage and Medical Necessity Criteria

inv-01: Initial therapy (percutaneous PTNS) — Covered when ALL of the following are met

Covered when ALL of the following are met

Initial PTNS criteria: A. Diagnosis of overactive bladder (OAB); B. Failure of conservative medical management (e.g., behavioral therapies such as bladder training or pelvic floor muscle training, or pharmacotherapy with oral medications used with the intent to treat OAB), unless conservative management is not desired or is medically contraindicated; C. Service is provided in accordance with the standard treatment regimen of 30-minute weekly sessions for 12 weeks.

Responders often show improvement after 6-8 sessions.

inv-02: Maintenance therapy — Covered when ALL of the following are met

Covered when ALL of the following are met

Maintenance PTNS: Once-a-month maintenance treatments with PTNS are medically necessary for patients who experience significant improvement in their OAB symptoms after the 12 initial treatments. Treatment frequency may vary depending on return of symptoms.

Policy Summary

PayerAmbetter Nevada

PolicyPosterior Tibial Nerve Stimulation for Voiding Dysfunction

Policy CodePolicy CP.MP.133

Change TypeRevisions to conservative management examples and coding updates

Effective Date

Next Review Date

Key ActionObtain prior authorization for percutaneous PTNS (CPT 64566) and document diagnosis of OAB, prior failure of conservative management, and planned 12 weekly 30-minute sessions.

SourceLink

On This Page

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Coding Guidance

CPT codes that support medical necessityCPTCovered

64566

Posterior tibial neurostimulation, percutaneous needle electrode, single treatment, includes programming

CPT codes that do not support medical necessity (implantable systems/programming)CPTNot Covered

0587T	Percutaneous implantation or replacement of integrated single device neurostimulation system for bladder dysfunction including electrode array and receiver or pulse generator, including analysis, programming and imaging guidance when performed, posterior tibial nerve.
0588T	Revision or removal of percutaneously placed integrated single device neurostimulation system for bladder dysfunction including electrode array and receiver or pulse generator, including analysis, programming, and imaging guidance when performed, posterior tibial nerve.
0589T	Electronic analysis with simple programming of implanted integrated neurostimulation system for bladder dysfunction (eg, electrode array and receiver), including contact group(s), amplitude, pulse width, frequency (Hz), on/off cycling, burst, dose lockout, patient-selectable parameters, responsive neurostimulation, detection algorithms, closed-loop parameters, and passive parameters, when performed by physician or other qualified health care professional, posterior tibial nerve, 1-3 parameters.
0590T	Electronic analysis with complex programming of implanted integrated neurostimulation system for bladder dysfunction (eg, electrode array and receiver), including contact group(s), amplitude, pulse width, frequency (Hz), on/off cycling, burst, dose lockout, patient-selectable parameters, responsive neurostimulation, detection algorithms, closed-loop parameters, and passive parameters, when performed by physician or other qualified health care professional, posterior tibial nerve, 4 or more parameters.

inv-08: Initial treatment course — 12 weekly 30-minute sessions (key treatment parameters)

Standard regimen12 weekly sessions of posterior tibial nerve stimulation

Session durationEach session is 30 minutes of stimulation

Typical response timeframeResponders often show improvement after 6–8 sessions

Stimulation parametersLow-voltage stimulation at 0.5–9 mA and ~20 Hz per session

Provider Requirements and Authorization

Prior Authorization

Prior Authorization Required

Prior authorization is required for percutaneous posterior tibial nerve stimulation (PTNS) when billed with CPT 64566. Requests should document diagnosis of overactive bladder (OAB), prior conservative management attempts (unless contraindicated or not desired), and that the planned regimen follows the standard 30-minute weekly sessions for 12 weeks. Monthly maintenance treatments may be considered if the member experiences significant improvement after the initial 12 treatments; frequency may vary based on symptom return.

Affected code: CPT 64566 — Posterior tibial neurostimulation, percutaneous needle electrode, single treatment, includes programming
Prior conservative management required: behavioral therapies (e.g., bladder training, pelvic floor muscle training) or pharmacotherapy unless not desired or medically contraindicated
Standard initial regimen: 30-minute sessions once weekly for 12 weeks
Maintenance: once-monthly treatments may be medically necessary for responders; frequency individualized

Documentation Required

Conservative Management Prerequisite

Prior to authorization and delivery of PTNS, there must be documented failure of conservative medical management for OAB—unless the patient declines conservative therapy or it is medically contraindicated. Conservative measures include behavioral therapies (bladder training, pelvic floor muscle training) and pharmacologic therapy with OAB medications. Documentation should include the therapies tried, duration, response, and reason for discontinuation if applicable.

Documented conservative management attempts (examples): bladder training, pelvic floor muscle training, and a trial of oral OAB medication(s)
If conservative measures were not tried, document clinical reason (patient preference or medical contraindication)
Include dates, duration, and outcomes of prior therapies

Billing Rule

Implantable Device Coding Risks

Exercise caution when using implantable tibial nerve stimulation codes. Implantable systems and their associated implantation, removal, and programming codes (including CPT 0587T–0590T and similar implantable device codes) are considered not supported by the evidence for treatment of urinary voiding dysfunction and do not meet medical necessity per this policy. Use of implantable device CPT codes may result in denial.

Do not bill CPT 0587T, 0588T, 0589T, or 0590T for PTNS treatment — these codes are listed as not supporting medical necessity
If an implantable device was placed or is being considered, provide clear clinical rationale and supporting evidence; anticipate coverage review and potential denial
Percutaneous PTNS is supported by CPT 64566; implantable tibial nerve stimulation lacks sufficient evidence per policy

Key Definitions

inv-14: Overactive bladder (OAB) — definition and core symptoms

DefinitionOveractive bladder (OAB) is a type of voiding dysfunction characterized by urinary urgency, urinary frequency, urge incontinence, and nocturia

ImpactOAB can significantly affect quality of life, including physical, sexual, and social functioning

Common conservative treatmentsLifestyle changes, bladder training, pelvic floor muscle training, and anticholinergic (anti‑muscarinic) medications

inv-15: Posterior tibial nerve stimulation (PTNS) — brief description of the procedure

Procedure descriptionPercutaneous posterior tibial nerve stimulation uses a 34‑gauge needle electrode placed near the posterior tibial nerve (≈5 cm cephalad to the medial malleolus and 2 cm posterior to the tibia) with a surface electrode on the medial foot

MechanismIndirect neuromodulation of the sacral nerve plexus via stimulation of the posterior tibial nerve

Typical stimulation detailsConnected to a low‑voltage electrical stimulator delivering 0.5–9 mA at ~20 Hz for about 30 minutes per session

Treatment courseInitial regimen typically 12 weekly sessions; maintenance sessions may be required to sustain response

OpenPayer

Posterior Tibial Nerve Stimulation for Voiding Dysfunction

Coverage and Medical Necessity Criteria

Coding Guidance

Provider Requirements and Authorization

Clinical Background

Key Definitions